I guess there will be no cap raising now for this one, with the funding in place.I feel not a bad investment at 0.004 ?? Anyone else any thoughts James
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%